Cargando…

Etanercept in the treatment of rheumatoid arthritis

Etanercept (ETN) is the first anti-tumor necrosis factor (TNF) agent to be approved for the treatment of rheumatoid arthritis (RA). Over the last 8 years, several clinical trials have shown its efficacy and safety in established and early RA, as well as a monotherapy or in combination with methotrex...

Descripción completa

Detalles Bibliográficos
Autores principales: Haraoui, Boulos, Bykerk, Vivian
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936291/
https://www.ncbi.nlm.nih.gov/pubmed/18360618

Ejemplares similares